Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.

Jaeger, U, Trneny, M, Melzer, H, Praxmarer, M, Nawarawong, W, Ben Yehuda, D, Goldstein, D, Mihaljevic, B, Ilhan, O, Ballova, V, Hedenus, M, Hsiao, LT, Au, WY, Burgstaller, S, Weidinger, G, Keil, F, Dittrich, C, Skrabs, C, Klingler, A, Chott, A, Fridrik, MA, Greil, R.

http://www.ncbi.nlm.nih.gov/pubmed/25911553